Journal of Molecular Medicine
Please note, we are currently updating the 2018 Journal Metrics.
The Journal of Molecular Medicine publishes original research articles and review articles that range from basic findings in mechanisms of disease pathogenesis to therapy. The focus includes all human diseases, including but not limited to:
Aging, angiogenesis, autoimmune diseases as well as other inflammatory diseases, cancer, cardiovascular diseases, development and differentiation, endocrinology, gastrointestinal diseases and hepatology, genetics and epigenetics, hematology, hypoxia research, immunology, infectious diseases, metabolic disorders, neuroscience of diseases, -omics based disease research, regenerative medicine, and stem cell research.
Studies solely based on cell lines will not be considered. Studies that are based on model organisms will be considered as long as they are directly relevant to human disease.
J Mol Med is the continuation of the Berliner Klinische Wochenschrift (1864), one of the oldest and most prestigious European journals in which great scientists such as Paul Ehrlich, Robert Koch and Otto Warburg published their seminal, epoch-making discoveries.
Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions
- Journal Title
- Journal of Molecular Medicine
- Volume 1 / 1922 - Volume 97 / 2019
- Print ISSN
- Online ISSN
- Springer Berlin Heidelberg
- Additional Links
- Industry Sectors
|Previous Title||Print ISSN||Online ISSN|
|The clinical investigator||0941-0198||1432-1440|
To view the rest of this content please follow the download PDF link above.